Personalized Cancer Vaccines Market Report

China Personalized Cancer Vaccines Industry Market Research Report 2023-2029

  • POSTDATE：Sep 04, 2023
  • PAGES：164
  • REPORT CODE：GMM1775858
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Personalized Cancer Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merck

    • BioNtech

    • CureVac AG

    • ISA Pharmaceuticals

    • Moderna Therapeutics

    • Hoffmann-La Roche Ltd

    • Celldex

    • Genocea

    • Personalis

    • Gritstone Oncology

    By Type:

    • Cervical Cancer

    • By Mechanism of Action Type

    • Lung Cancer

    • Breast Cancer

    • Tumor-associated antigens (TAAs)

    • Leukemia

    • Glioblastoma

    • By Cancer Type

    • Prostate Cancer

    • Colorectal Cancer

    • Pharmacogenomics towards Genomic Polymorphism

    • Somatic Mutations in Cancer Pharmacogenomics

    • Others

    • Tumor-specific antigens (TSAs)

    By Application:

    • Specialty Clinics

    • Others

    • Homecare

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Personalized Cancer Vaccines Market Overview 2018-2029

    • 1.1 China Personalized Cancer Vaccines Industry Development Overview

    • 1.2 China Personalized Cancer Vaccines Industry Development History

    • 1.3 China Personalized Cancer Vaccines Industry Market Size (2018-2029)

    • 1.4 China Personalized Cancer Vaccines Market Analysis by Type from Production Side

      • 1.4.1 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Cervical Cancer (2018-2029)

      • 1.4.2 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of By Mechanism of Action Type (2018-2029)

      • 1.4.3 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Lung Cancer (2018-2029)

      • 1.4.4 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Breast Cancer (2018-2029)

      • 1.4.5 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Tumor-associated antigens (TAAs) (2018-2029)

      • 1.4.6 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Leukemia (2018-2029)

      • 1.4.7 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Glioblastoma (2018-2029)

      • 1.4.8 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of By Cancer Type (2018-2029)

      • 1.4.9 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Prostate Cancer (2018-2029)

      • 1.4.10 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Colorectal Cancer (2018-2029)

      • 1.4.11 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Pharmacogenomics towards Genomic Polymorphism (2018-2029)

      • 1.4.12 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Somatic Mutations in Cancer Pharmacogenomics (2018-2029)

      • 1.4.13 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.14 China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Tumor-specific antigens (TSAs) (2018-2029)

    • 1.5 China Personalized Cancer Vaccines Market Analysis by Application from Consumption End

      • 1.5.1 China Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)

      • 1.5.2 China Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate of Homecare (2018-2029)

      • 1.5.4 China Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China Personalized Cancer Vaccines Market Analysis by Region

      • 1.6.1 North China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

    Chapter 2 China Personalized Cancer Vaccines Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Personalized Cancer Vaccines Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Personalized Cancer Vaccines Market Status and Competition Analysis in 2023

      • 2.2.3 China Personalized Cancer Vaccines Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Personalized Cancer Vaccines Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Personalized Cancer Vaccines Industry Development

    Chapter 3 Personalized Cancer VaccinesIndustry Chain Analysis

    • 3.1 Personalized Cancer Vaccines Industry Chain

    • 3.2 Personalized Cancer Vaccines Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Personalized Cancer Vaccines Market

    • 3.3 Personalized Cancer Vaccines Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Personalized Cancer Vaccines Market

    Chapter 4 China Personalized Cancer Vaccines Market, by Type

    • 4.1 China Personalized Cancer Vaccines Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Personalized Cancer Vaccines Total Production Volume and Growth Rate from Production Side

    • 4.5 China Personalized Cancer Vaccines Production Volume and Growth Rate, by Type

      • 4.5.1 China Personalized Cancer Vaccines Production Volume and Growth Rate of Cervical Cancer

      • 4.5.2 China Personalized Cancer Vaccines Production Volume and Growth Rate of By Mechanism of Action Type

      • 4.5.3 China Personalized Cancer Vaccines Production Volume and Growth Rate of Lung Cancer

      • 4.5.4 China Personalized Cancer Vaccines Production Volume and Growth Rate of Breast Cancer

      • 4.5.5 China Personalized Cancer Vaccines Production Volume and Growth Rate of Tumor-associated antigens (TAAs)

      • 4.5.6 China Personalized Cancer Vaccines Production Volume and Growth Rate of Leukemia

      • 4.5.7 China Personalized Cancer Vaccines Production Volume and Growth Rate of Glioblastoma

      • 4.5.8 China Personalized Cancer Vaccines Production Volume and Growth Rate of By Cancer Type

      • 4.5.9 China Personalized Cancer Vaccines Production Volume and Growth Rate of Prostate Cancer

      • 4.5.10 China Personalized Cancer Vaccines Production Volume and Growth Rate of Colorectal Cancer

      • 4.5.11 China Personalized Cancer Vaccines Production Volume and Growth Rate of Pharmacogenomics towards Genomic Polymorphism

      • 4.5.12 China Personalized Cancer Vaccines Production Volume and Growth Rate of Somatic Mutations in Cancer Pharmacogenomics

      • 4.5.13 China Personalized Cancer Vaccines Production Volume and Growth Rate of Others

      • 4.5.14 China Personalized Cancer Vaccines Production Volume and Growth Rate of Tumor-specific antigens (TSAs)

    Chapter 5 China Personalized Cancer Vaccines Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Personalized Cancer Vaccines Total Market Size and Growth Rate from Consumption End

    • 5.5 China Personalized Cancer Vaccines Market Size and Growth Rate, by Application

      • 5.5.1 China Personalized Cancer Vaccines Market Size and Growth Rate of Specialty Clinics

      • 5.5.2 China Personalized Cancer Vaccines Market Size and Growth Rate of Others

      • 5.5.3 China Personalized Cancer Vaccines Market Size and Growth Rate of Homecare

      • 5.5.4 China Personalized Cancer Vaccines Market Size and Growth Rate of Hospitals

    Chapter 6 China Personalized Cancer Vaccines Market, by Region

    • 6.1 China Personalized Cancer Vaccines Production Volume and Production Value, by Region

    • 6.2 China Personalized Cancer Vaccines Sales Volume and Sales Value, by Region

    Chapter 7 North China Personalized Cancer Vaccines Market Analysis

    • 7.1 North China Personalized Cancer Vaccines Market, by Type

    • 7.2 North China Personalized Cancer Vaccines Market, by Application

    Chapter 8 Central China Personalized Cancer Vaccines Market Analysis

    • 8.1 Central China Personalized Cancer Vaccines Market, by Type

    • 8.2 Central China Personalized Cancer Vaccines Market, by Application

    Chapter 9 South China Personalized Cancer Vaccines Market Analysis

    • 9.1 South China Personalized Cancer Vaccines Market, by Type

    • 9.2 South China Personalized Cancer Vaccines Market, by Application

    Chapter 10 East China Personalized Cancer Vaccines Market Analysis

    • 10.1 East China Personalized Cancer Vaccines Market, by Type

    • 10.2 East China Personalized Cancer Vaccines Market, by Application

    Chapter 11 Northeast China Personalized Cancer Vaccines Market Analysis

    • 11.1 Northeast China Personalized Cancer Vaccines Market, by Type

    • 11.2 Northeast China Personalized Cancer Vaccines Market, by Application

    Chapter 12 Southwest China Personalized Cancer Vaccines Market Analysis

    • 12.1 Southwest China Personalized Cancer Vaccines Market, by Type

    • 12.2 Southwest China Personalized Cancer Vaccines Market, by Application

    Chapter 13 Northwest China Personalized Cancer Vaccines Market Analysis

    • 13.1 Northwest China Personalized Cancer Vaccines Market, by Type

    • 13.2 Northwest China Personalized Cancer Vaccines Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merck

        • 14.1.1 Merck Company Profile

        • 14.1.2 Merck Personalized Cancer Vaccines Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 BioNtech

        • 14.2.1 BioNtech Company Profile

        • 14.2.2 BioNtech Personalized Cancer Vaccines Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 CureVac AG

        • 14.3.1 CureVac AG Company Profile

        • 14.3.2 CureVac AG Personalized Cancer Vaccines Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 ISA Pharmaceuticals

        • 14.4.1 ISA Pharmaceuticals Company Profile

        • 14.4.2 ISA Pharmaceuticals Personalized Cancer Vaccines Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Moderna Therapeutics

        • 14.5.1 Moderna Therapeutics Company Profile

        • 14.5.2 Moderna Therapeutics Personalized Cancer Vaccines Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Hoffmann-La Roche Ltd

        • 14.6.1 Hoffmann-La Roche Ltd Company Profile

        • 14.6.2 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Celldex

        • 14.7.1 Celldex Company Profile

        • 14.7.2 Celldex Personalized Cancer Vaccines Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Genocea

        • 14.8.1 Genocea Company Profile

        • 14.8.2 Genocea Personalized Cancer Vaccines Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Personalis

        • 14.9.1 Personalis Company Profile

        • 14.9.2 Personalis Personalized Cancer Vaccines Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Gritstone Oncology

        • 14.10.1 Gritstone Oncology Company Profile

        • 14.10.2 Gritstone Oncology Personalized Cancer Vaccines Market Performance

        • 14.10.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Personalized Cancer Vaccines Industry Research Conclusions

    • 15.2 Personalized Cancer Vaccines Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Personalized Cancer Vaccines Industry Market Size (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Cervical Cancer (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of By Mechanism of Action Type (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Lung Cancer (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Tumor-associated antigens (TAAs) (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Leukemia (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Glioblastoma (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of By Cancer Type (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Prostate Cancer (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Colorectal Cancer (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Pharmacogenomics towards Genomic Polymorphism (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Somatic Mutations in Cancer Pharmacogenomics (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Personalized Cancer Vaccines Production Volume, Production Value and Growth Rate of Tumor-specific antigens (TSAs) (2018-2029)

    • Figure China Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)

    • Figure China Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate of Homecare (2018-2029)

    • Figure China Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Central China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

    • Figure South China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

    • Figure East China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Personalized Cancer Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Personalized Cancer Vaccines Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Personalized Cancer Vaccines Market Share by Type in 2018

    • Figure China Personalized Cancer Vaccines Market Share by Type in 2023

    • Figure China Personalized Cancer Vaccines Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of Cervical Cancer (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of By Mechanism of Action Type (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of Lung Cancer (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of Breast Cancer (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of Tumor-associated antigens (TAAs) (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of Leukemia (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of Glioblastoma (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of By Cancer Type (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of Prostate Cancer (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of Colorectal Cancer (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of Pharmacogenomics towards Genomic Polymorphism (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of Somatic Mutations in Cancer Pharmacogenomics (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume and Growth Rate of Tumor-specific antigens (TSAs) (2018-2023)

    • Figure China Personalized Cancer Vaccines Market Share by Application in 2018

    • Figure China Personalized Cancer Vaccines Market Share by Application in 2023

    • Figure China Personalized Cancer Vaccines Total Market Size and Growth Rate from Consumption End

    • Figure China Personalized Cancer Vaccines Market Size and Growth Rate of Specialty Clinics (2018-2023)

    • Figure China Personalized Cancer Vaccines Market Size and Growth Rate of Others (2018-2023)

    • Figure China Personalized Cancer Vaccines Market Size and Growth Rate of Homecare (2018-2023)

    • Figure China Personalized Cancer Vaccines Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China Personalized Cancer Vaccines Production Volume by Region (2018-2023)

    • Table China Personalized Cancer Vaccines Production Volume Share by Region (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Volume Share by Region (2018-2023)

    • Table China Personalized Cancer Vaccines Production Value by Region (2018-2023)

    • Table China Personalized Cancer Vaccines Production Value Share by Region (2018-2023)

    • Figure China Personalized Cancer Vaccines Production Value Share by Region (2018-2023)

    • Table China Personalized Cancer Vaccines Sales Volume by Region (2018-2023)

    • Table China Personalized Cancer Vaccines Sales Volume Share by Region (2018-2023)

    • Figure China Personalized Cancer Vaccines Sales Volume Share by Region (2018-2023)

    • Table China Personalized Cancer Vaccines Sales Value by Region (2018-2023)

    • Table China Personalized Cancer Vaccines Sales Value Share by Region (2018-2023)

    • Figure China Personalized Cancer Vaccines Sales Value Share by Region (2018-2023)

    • Table North China Personalized Cancer Vaccines Production Volume by Type (2018-2023)

    • Table North China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Figure North China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Table North China Personalized Cancer Vaccines Sales Volume by Application (2018-2023)

    • Table North China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Figure North China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Table Central China Personalized Cancer Vaccines Production Volume by Type (2018-2023)

    • Table Central China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Figure Central China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Table Central China Personalized Cancer Vaccines Sales Volume by Application (2018-2023)

    • Table Central China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Central China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Table South China Personalized Cancer Vaccines Production Volume by Type (2018-2023)

    • Table South China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Figure South China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Table South China Personalized Cancer Vaccines Sales Volume by Application (2018-2023)

    • Table South China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Figure South China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Table East China Personalized Cancer Vaccines Production Volume by Type (2018-2023)

    • Table East China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Figure East China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Table East China Personalized Cancer Vaccines Sales Volume by Application (2018-2023)

    • Table East China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Figure East China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northeast China Personalized Cancer Vaccines Production Volume by Type (2018-2023)

    • Table Northeast China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northeast China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Table Northeast China Personalized Cancer Vaccines Sales Volume by Application (2018-2023)

    • Table Northeast China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Table Southwest China Personalized Cancer Vaccines Production Volume by Type (2018-2023)

    • Table Southwest China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Figure Southwest China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Table Southwest China Personalized Cancer Vaccines Sales Volume by Application (2018-2023)

    • Table Southwest China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northwest China Personalized Cancer Vaccines Production Volume by Type (2018-2023)

    • Table Northwest China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northwest China Personalized Cancer Vaccines Production Volume Share by Type (2018-2023)

    • Table Northwest China Personalized Cancer Vaccines Sales Volume by Application (2018-2023)

    • Table Northwest China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Personalized Cancer Vaccines Sales Volume Share by Application (2018-2023)

    • Table Merck Company Profile

    • Table Merck Personalized Cancer Vaccines Revenue, Price and Gross (2018-2023)

    • Table BioNtech Company Profile

    • Table BioNtech Personalized Cancer Vaccines Revenue, Price and Gross (2018-2023)

    • Table CureVac AG Company Profile

    • Table CureVac AG Personalized Cancer Vaccines Revenue, Price and Gross (2018-2023)

    • Table ISA Pharmaceuticals Company Profile

    • Table ISA Pharmaceuticals Personalized Cancer Vaccines Revenue, Price and Gross (2018-2023)

    • Table Moderna Therapeutics Company Profile

    • Table Moderna Therapeutics Personalized Cancer Vaccines Revenue, Price and Gross (2018-2023)

    • Table Hoffmann-La Roche Ltd Company Profile

    • Table Hoffmann-La Roche Ltd Personalized Cancer Vaccines Revenue, Price and Gross (2018-2023)

    • Table Celldex Company Profile

    • Table Celldex Personalized Cancer Vaccines Revenue, Price and Gross (2018-2023)

    • Table Genocea Company Profile

    • Table Genocea Personalized Cancer Vaccines Revenue, Price and Gross (2018-2023)

    • Table Personalis Company Profile

    • Table Personalis Personalized Cancer Vaccines Revenue, Price and Gross (2018-2023)

    • Table Gritstone Oncology Company Profile

    • Table Gritstone Oncology Personalized Cancer Vaccines Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US